Clinical failure of vancomycin in a dialysis patient with methicillin-susceptible vancomycin-heteroresistant S. aureus

Diagnostic Microbiology and Infectious Disease

Volumn 65, Issue 2, 2009, Pages 180-183

  Fusco, Dahlene N ^a   Alexander, Elizabeth L ^a   Weisenberg, Scott A ^a   Mediavilla, Jose R ^c   Kreiswirth, Barry N ^c   Schuetz, Audrey N ^b   Jenkins, Stephen G ^b   Rhee, Kyu Y ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Failure; Heteroresistance; Staphylococcus aureus; Vancomycin

Indexed keywords

INDIUM; METICILLIN; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BLOOD CULTURE; CASE REPORT; COXITIS; DEBRIDEMENT; DISKITIS; DRUG BLOOD LEVEL; DRUG TREATMENT FAILURE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HIP PAIN; HOSPITAL DISCHARGE; HUMAN; KIDNEY FAILURE; LOW BACK PAIN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT INFECTION; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; TREATMENT DURATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTEREMIA; FEMALE; HUMANS; METHICILLIN; MIDDLE AGED; RENAL DIALYSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT FAILURE; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 69949100714     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.05.017     Document Type: Article

References (12)

1. Bernard L., Vaudaux P., Rohner P., Huggler E., Armanet M., Pittet D., Lew D.P., and Schrenzel J. Comparative analysis and validation of different assays for glycopeptides susceptibility among methicillin-resistant Staphylococcus aureus strains. J. Microbiol. Methods 57 (2004) 231-239
2. Bobin-Dubreux S., Reverdy M., Nervi C., Rougier M., Bolmström A., Vandenesch F., and Etienne J. Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative. Antimicrob. Agents Chemother. 45 (2001) 349-352
3. Charles P., Ward P., Johnson P., Howden B., and Grayson M. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin. Infect. Dis. 38 (2004) 448-451
4. Fowler Jr. V.G., Miro J.M., Hoen B., Cabell C.H., Abrutyn E., Rubinstein E., Corey G.R., Spelman D., Bradley S.F., Barsic B., Pappas P.A., Anstrom K.J., Wray D., Fortes C.Q., Anguera I., Athan E., Jones P., van der Meer J.T., Elliott T.S., Levine D.P., Bayer A.S., and ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293 (2005) 3012-3021
5. Hiramatsu K., Hanaki H., Ino T., Yabuta K., Oguri T., and Tenover F. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40 (1997) 135-136
6. Mulver M., Chui L., Ismail J., Louie L., Murph C., Chang N., Alfa M., and Canadian Committee for the Standardization of Molecular Methods. Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J Clin. Microbiol. 39 (2001) 3481-3485
7. Rossney A., Herra C., Brennan G., Morgan P., and O'Connell B. Evaluation of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay using the GeneXpert real-time PCR platform for rapid detection of MRSA from screening specimens. J. Clin. Microbiol. 46 (2008) 3285-3290
8. Rybak M., Leonard S., Rossi K., Cheung C., Sadar H., and Jones R. Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (from 1986 to 2007). J. Clin. Microbiol. 46 (2008) 2950-2954
9. Sakoulas G., and Moellering R. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin. Infect. Dis. 46 (2008) S360-S367
10. Sieradzki K., Roberts R., Haber S., and Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N. Engl. J. Med. 340 (1999) 517-523
11. Wootton M., MacGowan A., Walsh T., and Howe R. A multicenter study for evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J. Clin. Microbiol. 45 (2007) 329-332
12. Yusof A., Engelhardt A., Karlson A., Bylund L., Vidh P., Mills K., Wootton M., and Walsh T.R. Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA) in particular, heterogeneous GISA. J. Clin. Microbiol. 46 (2008) 3042-3047